About
Global technology-driven CDMO providing end-to-end tern key services, from product development through commercial manufacturing and packaging
Areas of Focus
Categories
Contract ResearchContract ResearchCg RegulatoryNJ, NY, PA
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
1
As Collaborator
3
Total Enrollment
262
By Phase
NA: 1PHASE1: 2
By Status
COMPLETED: 3TERMINATED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Today
Hover over trial bars to see details
Recent Trials
NCT03598673Collaborator
To Determine the Effect of Nebivolol on Office Blood Pressure of Blacks Residing in Nigeria
N/ACompleted
200 participants
Started: Feb 27, 2018 · Completed: Apr 27, 2019
NCT00665002Collaborator
Pilot Trial of a WT-1 Analog Peptide Vaccine in Patients With Myeloid Neoplasms
NACompleted
16 participants
Started: Jun 30, 2008 · Completed: Feb 28, 2015
NCT00398138Collaborator
Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma
PHASE1Completed
22 participants
Started: Oct 31, 2006 · Completed: Jun 30, 2009
NCT00255333Lead Sponsor
INNO-105 in Patients With Solid Tumors
PHASE1Terminated
24 participants
Started: Nov 30, 2005 · Completed: Mar 31, 2007
Locations (1)
Headquarters
Monroe, NJ, United States
Map
Loading map...